Affiliation:
1. Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) Berlin Germany
2. Charité‐Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt‐Universität zu Berlin Berlin Germany
3. Experimental and Clinical Research Center Charité‐Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine Berlin Germany
4. German Centre for Cardiovascular Research (DZHK) Partner Site Berlin Berlin Germany
5. Department of Cardiology, Angiology and Intensive Care Medicine Deutsches Herzzentrum der Charité – Medical Heart Center of Charité and German Heart Institute Berlin Berlin Germany
6. Max Rubner Center for Cardiovascular Metabolic Renal Research (MRC), Deutsches Herzzentrum der Charité (DHZC) Charité – Universitätsmedizin Berlin Berlin Germany
Abstract
AbstractA unique interplay between body and environment embeds and reflects host–microbiome interactions that contribute to sex‐differential disease susceptibility, symptomatology, and treatment outcomes. These differences derive from individual biological factors, such as sex hormone action, sex‐divergent immune processes, X‐linked gene dosage effects, and epigenetics, as well as from their interaction across the lifespan. The gut microbiome is increasingly recognized as a moderator of several body systems that are thus impacted by its function and composition. In humans, biological sex components further interact with gender‐specific exposures such as dietary preferences, stressors, and life experiences to form a complex whole, requiring innovative methodologies to disentangle. Here, we summarize current knowledge of the interactions among sex hormones, gut microbiota, immune system, and vascular health and their relevance for sex‐differential epidemiology of cardiovascular diseases. We outline clinical implications, identify knowledge gaps, and place emphasis on required future studies to address these gaps. In addition, we provide an overview of the caveats associated with conducting cardiovascular research that require consideration of sex/gender differences. While previous work has inspected several of these components separately, here we call attention to further translational utility of a combined perspective from cardiovascular translational research, gender medicine, and microbiome systems biology.